Screener
Hemab Therapeutics Holdings, Inc. COAG Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Hemab Therapeutics Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Hemab Therapeutics Holdings, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-344533
FAQ
- What is Hemab Therapeutics Holdings, Inc.'s current ratio?
- Hemab Therapeutics Holdings, Inc. (COAG) reported current ratio of 35.8× in Q2 2026.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Hemab Therapeutics Holdings, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude